Clinical Trials Browser

Phase 2/3 × anlotinib × Sarcoma × Clear all

NCT02449343 2017-04-25

Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)

Phase 2/3 Unknown

Sarcoma